Physician profile

Christopher D Galli

Foot & Ankle Surgery · Carmichael, CA

NPI 1740785021

$14,446.26

in general payments reported to CMS, 2019-2025

40 companies · $1,566 in 2025

The $1,566 reported for 2025 was more than what 79% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).

See the full distribution for Foot & Ankle Surgery

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$5,113.02
Travel and Lodging$1,492.01

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Stryker Corporation $7,823.99 2021-2025 Prostep, Augment Injectable, Actishield
Paragon 28, INC. $2,519.58 2022-2025 Portfolio, Precision Mis Bunion
Bioventus LLC $467.98 2022-2025 Exogen Ultrasound Bone Healing System
Sportstek Medical, INC $436.00 2019
Smith+Nephew, INC. $342.01 2021-2025 Evos, Renasys, Large Qwix
Globus Medical, INC. $229.42 2023-2025 Senza, Mini Fragment System, Ankle Fracture System
Orthofix Medical, INC. $217.89 2023-2025 Physio-Stim
Depuy Synthes Sales INC. $187.94 2021-2025 Motoband
Trilliant Surgical LLC. $179.92 2023-2024 Arsenal Ankle 10 Hole 1/3 Tubular Plate, Arsenal Sinus Support Plate
Ets Wound Care LLC $152.23 2025 Mirragen Advanced Wound Matrix
Treace Medical Concepts, INC. $142.59 2023-2025
Avita Medical Americas, LLC $142.15 2024
Nevro Corp. $137.50 2021-2022
Next Science LLC $129.00 2022
Musculoskeletal Transplant Foundation INC. $128.07 2023
Show all 40 companies
CompanyGeneral paymentsYearsTop products
Evolution Surgical, INC $126.63 2024-2025
Biotissue Holdings INC. $108.78 2023
Cardiovascular Systems INC. $85.21 2022
Medshape, INC. $79.58 2025 Dynaclip Bone Fixation System, Quattro, 22mm X 20mm X 20mm, Dynanail
Linvatec Corporation $75.47 2025 Biobrace 23mm, Anchor
Integra Lifesciences Corporation $74.27 2021
Zimvie INC. $70.87 2022-2023
Kerecis Limited $65.37 2025 Kerecis Surgiclose, Kerecis Graftguide
Exactech, INC. $62.08 2024
Restor3d, INC. $58.49 2025
Medtronic, INC. $44.17 2022-2023 Intellis Adaptivestim
Hartmann USA, INC. $42.08 2022-2023 Zetuvit Plus
Horizon Therapeutics Plc $38.14 2023 Krystexxa
Curonix LLC $32.33 2025 Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A
Vericel Corporation $25.74 2023 Maci
Convatec INC. $24.44 2023
Paratek Pharmaceuticals, INC. $24.36 2025 Nuzyra
Amgen INC. $24.32 2025 Krystexxa
Ethicon US, LLC $23.64 2022
Heron Therapeutics, INC. $22.19 2021
Ortho Dermatologics, A Division of Bausch Health US, LLC $21.54 2025 Jublia
Novastep INC. $20.88 2025 Nexis
Averitas Pharma INC. $20.57 2023 Qutenza
Fusion Orthopedics USA, LLC $20.04 2024
Melinta Therapeutics, LLC $18.80 2022

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Christopher D Galli

$14,446.26

in general payments reported 2019-2025

Years
2019-2025
Top company
Stryker Corporation
Context
The $1,566 reported for 2025 was more than what 79% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).

https://glasscript.com/doctor/7228694/christopher-d-galli

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.